newsfilter
← Latest News
GlobeNewswire·

Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference

STAMFORD, Conn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Chri